In our research, NF-κB-dependent signaling was activated in SE rats, and losmapimod treatment may alleviate SE pilocarpine-induced epilepsy by inhibiting the activation of MAPK/NF-κB-dependent signaling. Here, NFKB1 is linked to epilepsy.